Jesica Swanstrom

Title: Jesica Swanstrom: Innovator in Vaccine Development

Introduction

Jesica Swanstrom is a prominent inventor based in Morrisville, NC (US). She has made significant contributions to the field of vaccine development, particularly in the area of viral diseases. With a total of 2 patents, her work focuses on innovative methods and compositions that enhance vaccine efficacy.

Latest Patents

One of her latest patents is titled "Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development." This invention provides compositions and methods of use that include a chimeric dengue virus E glycoprotein. This glycoprotein backbone features amino acid substitutions that introduce an epitope recognized by an antibody from a different dengue virus serotype. Another notable patent is "Methods and compositions for norovirus blockade epitopes." This invention offers methods and compositions that comprise a chimeric norovirus capsid protein. The capsid protein backbone includes a norovirus epitope selected from various options, ensuring versatility in targeting different norovirus strains.

Career Highlights

Jesica Swanstrom is affiliated with the University of North Carolina at Chapel Hill, where she conducts her research and development work. Her innovative approaches have positioned her as a key figure in the field of infectious disease research.

Collaborations

Throughout her career, Jesica has collaborated with esteemed colleagues such as Ralph Baric and Kari Moore Debbink. These partnerships have furthered her research and contributed to the advancement of vaccine technologies.

Conclusion

Jesica Swanstrom's contributions to vaccine development through her innovative patents highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in combating viral diseases.